Report

reporttype2Version of Safety Report ID2receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10076982serious1Date Last Updated14/04/2014receiptdateformat102companynumbAU-SANOFI-AVENTIS-2013SA092171occurcountryAUseriousnessother1duplicate1Date Received14/04/2014transmissiondate12/12/2014primarysourcecountryAU

Primary Source

reportercountryAUqualification1

Patient

Onset Age30Unit of Onset AgeyearsWeight79SexFemale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
- 6)
- 7)
- 8)
- 9)
- 10)
- 11)
- 12)
- 13)
- 14)
- 15)
- 16)
- 17)
- 18)
- 19)
- 20)
- 21)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionSuicidal ideationOutcomeNot recovered/not resolved

2)

reactionmeddraversionpt17.0ReactionDepressionOutcomeRecovering/resolving

3)

reactionmeddraversionpt17.0ReactionPoor quality sleepOutcomeRecovering/resolving

4)

reactionmeddraversionpt17.0ReactionMood swingsOutcomeRecovering/resolving

5)

reactionmeddraversionpt17.0ReactionDepressed moodOutcomeRecovering/resolving

6)

reactionmeddraversionpt17.0ReactionEmotional distressOutcomeUnknown

7)

reactionmeddraversionpt17.0ReactionDecreased appetiteOutcomeUnknown

8)

reactionmeddraversionpt17.0ReactionFrequent bowel movementsOutcomeUnknown

9)

reactionmeddraversionpt17.0ReactionFatigueOutcomeNot recovered/not resolved

10)

reactionmeddraversionpt17.0ReactionStressOutcomeUnknown

11)

reactionmeddraversionpt17.0ReactionCoughOutcomeNot recovered/not resolved

12)

reactionmeddraversionpt17.0ReactionAstheniaOutcomeUnknown

13)

reactionmeddraversionpt17.0ReactionPostural tremorOutcomeNot recovered/not resolved

14)

reactionmeddraversionpt17.0ReactionTremorOutcomeNot recovered/not resolved

15)

reactionmeddraversionpt17.0ReactionGait disturbanceOutcomeUnknown

16)

reactionmeddraversionpt17.0ReactionGeneral physical health deteriorationOutcomeUnknown

17)

reactionmeddraversionpt17.0ReactionAffective disorderOutcomeUnknown

18)

reactionmeddraversionpt17.0ReactionParaesthesiaOutcomeUnknown

19)

reactionmeddraversionpt17.0ReactionAlopeciaOutcomeUnknown

20)

reactionmeddraversionpt17.0ReactionWeight decreasedOutcomeUnknown

21)

reactionmeddraversionpt17.0ReactionDiarrhoeaOutcomeRecovering/resolving

Drug

1)

drugcharacterization1medicinalproductAUBAGIOdrugbatchnumbUNKNOWNdrugauthorizationnumb202992drugstructuredosagenumb14drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosageformCOATED TABLETdrugadministrationroute048drugindicationRELAPSING-REMITTING MULTIPLE SCLEROSISdrugstartdateformat102drugstartdate16/06/2013actiondrug4

openFDA Info on Medication

Application NumberNDA202992Brand NameAUBAGIOGeneric NameTERIFLUNOMIDEManufacturersGenzyme Corporationproduct_ndc58468-0210, 58468-0211Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsTERIFLUNOMIDERXCUI1310525, 1310531, 1310533, 1310535spl_id00ccc1a2-a63c-418a-9f40-1792b505f2c8spl_set_id4650d12c-b9c8-4525-b07f-a2d773eca155Package NDC 58468-0211-1, 58468-0211-2, 58468-0211-4, 58468-0211-3, 58468-0210-2, 58468-0210 ... NUIN0000185502, N0000185501Established Pharmacologic ClassPyrimidine Synthesis Inhibitor [EPC]Mechanism of ActionDihydroorotate Dehydrogenase Inhibitors [MoA]UNII1C058IKG3B

2)

drugcharacterization2medicinalproductZOLOFTdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATION

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

3)

drugcharacterization2medicinalproductEPILIMdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATION

4)

drugcharacterization2medicinalproductENDEPdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATION

5)

drugcharacterization2medicinalproductSANDOMIGRANdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATION

Report Duplicate

duplicatesourceAVENTISduplicatenumbAU-SANOFI-AVENTIS-2013SA092171

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

9)

10)

11)

12)

13)

14)

15)

16)

17)

18)

19)

20)

21)

Drug

1)

openFDA Info on Medication

2)

openFDA Info on Medication

3)

4)

5)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us